Literature DB >> 27810311

Randomised trials in left main disease: a NOBLE effort.

Michael Mack1, David R Holmes2.   

Abstract

Mesh：

Year:  2016        PMID： 27810311     DOI： 10.1016/S0140-6736(16)32067-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

1.  Percutaneous coronary intervention in left main disease: SYNTAX, PRECOMBAT, EXCEL and NOBLE-combined cardiology and cardiac surgery perspective.

Authors:  Duk-Woo Park; Jung-Min Ahn; Seung-Jung Park; David P Taggart
Journal:  Ann Cardiothorac Surg       Date:  2018-07

Review 2.  Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting for the Treatment of Left Main Coronary Artery Disease.

Authors:  Sang Cheol Cho; Duk Woo Park; Seung Jung Park
Journal:  Korean Circ J       Date:  2019-05       Impact factor: 3.243
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.